Lisa K. Brents, Ph.D.

Affiliations: 
2013 Interdisciplinary Toxicology University of Arkansas for Medical Sciences, United States 
Area:
Pharmacology, Behavioral Psychology
Google:
"Lisa Brents"
Mean distance: 30533.1
 

Parents

Sign in to add mentor
Paul L. Prather grad student 2013 UAMS
 (Active metabolites and drug-drug interactions of the synthetic cannabinoids JWH-018 and JWH-073 at the Cannabinoid 1 Receptor.)
William E. Fantegrossi research scientist 2016- UAMS
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Griffin BA, Caperton CO, Russell LN, et al. (2019) exposure to norbuprenorphine, a major metabolite of buprenorphine, induces fetal opioid dependence and leads to neonatal opioid withdrawal syndrome. The Journal of Pharmacology and Experimental Therapeutics
Tai S, Hyatt WS, Gu C, et al. (2015) Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner. Pharmacological Research. 102: 22-32
Brents LK, Tripathi SP, Young J, et al. (2015) The role of childhood maltreatment in the altered trait and global expression of personality in cocaine addiction. Journal of Psychiatric Research. 64: 23-31
Marshell R, Kearney-Ramos T, Brents LK, et al. (2014) In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection. Pharmacology, Biochemistry, and Behavior. 124: 40-7
Brents LK, Prather PL. (2014) The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products. Drug Metabolism Reviews. 46: 72-85
Brents LK, Zimmerman SM, Saffell AR, et al. (2013) Differential drug-drug interactions of the synthetic cannabinoids JWH-018 and JWH-073: Implications for drug abuse liability and pain therapys Journal of Pharmacology and Experimental Therapeutics. 346: 350-361
Rajasekaran M, Brents LK, Franks LN, et al. (2013) Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. Toxicology and Applied Pharmacology. 269: 100-8
Madadi NR, Penthala NR, Brents LK, et al. (2013) Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptors. Bioorganic & Medicinal Chemistry Letters. 23: 2019-21
Chimalakonda KC, Seely KA, Bratton SM, et al. (2012) Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 2174-84
Seely KA, Brents LK, Franks LN, et al. (2012) AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies Neuropharmacology. 63: 905-915
See more...